{"nct_id":"NCT02270944","title":"Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine","status":"COMPLETED","status_verified_date":"2019-11","start_date":"2014-11-20","start_date_type":"ACTUAL","primary_completion_date":"2015-04-23","primary_completion_date_type":"ACTUAL","completion_date":"2015-09-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}